Pfizer raises future profit forecast

Source: Dukascopy Bank SA
Pfizer raised its 2025 profit forecast on strong Vyndaqel and Eliquis demand, despite a 20 cent a share charge from a cancer drug deal with China's 3SBio.
Back to articles

Actual Topics

Wed, 06 Aug 2025 06:30:05 GMT

Intel struggles on chip quality

Intel's key 18A chip tech faces quality issues, risking its plan to rival TSMC and boost U.S. chipmaking despite heavy investment in factories and R&D.

Tue, 05 Aug 2025 21:30:04 GMT

Palantir beats revenue estimates

Palantir topped $1B in Q2 revenue for the first time, beating estimates. EPS hit 16 cents per share.

Subscribe to "Fundamental Analysis" feed

Subscribe
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.